Following months of interviews with clients and peer law firms, analysts at Best Lawyers in America have again selected Nachawati Law Firm among its Tier I law firms for plaintiffs personal injury litigation.
The annual ranking is considered one of the most trusted nationwide guides to the U.S. legal industry. Firms earn recognition based on a comprehensive analysis that includes feedback from clients and peers related to expertise, responsiveness, whether they would refer a matter to a firm, and whether they consider a firm a worthy competitor.
“Our lawyers are passionate about their work, and obtaining justice for our clients is the ultimate reward,” said firm founder Majed Nachawati. “I’m proud of this group and their accomplishments, and I’m pleased that our work is appreciated by clients and noticed by our peers.”
To be eligible for Best Law Firms recognition, firms must have at least one lawyer individually recognized in the current edition of The Best Law Firms in America. Firm partners Majed Nachawati and Steven Schulte were honored in the 2023 edition of Best Lawyers. Only 4 percent of law firms ultimately receive the Best Law Firms recognition each year.
The trial lawyers at Nachawati Law Group represent individuals in a range of important litigation, which is often national in scope. That includes litigation related to injuries caused by defective products and devices, including products containing cancer-causing chemicals like Monsanto’s glyphosate-based Roundup herbicide and talc-based products such as Johnson & Johnson’s Baby Powder. The firm also represents state and local governments and other public entities in litigation over damages caused by highly addictive opioid painkillers and communities with water supplies tainted by PFAS “forever chemicals.”
This is only the most recent accolade for the Dallas-based firm. Earlier this year, the firm was highlighted among the top 3 most active law firms in the nation based on its representation of injured individuals, according to an analysis by Lex Machina.